Monthly Archives: February 2017

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses Exceeding $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against DaVita Inc. (“DaVita” or the “Company”) (NYSE: DVA). Investors, who purchased or otherwise acquired shares between August 5, 2015 and October 21, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

On January 6, 2017, the Wall Street Journal announced DaVita had received subpoenas from federal prosecutors for “the production of information related to charitable premium assistance” concerning the Company’s relationship with the American Kidney Fund, a charity that offers financial help for patients undergoing kidney dialysis. When this information was released to the public, the value of DaVita stock fell, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 456074

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Egalet Corporation (“Egalet” or the “Company”) (NASDAQ: EGLT). Investors, who purchased or otherwise acquired Egalet shares between December 15, 2015, and January 9, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 28, 2017 lead plaintiff deadline.

If you purchased shares of Egalet during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

On January 9, 2017, Egalet released a statement concerning approval for its product Arymo ER. The same day, the U.S. Federal Drug Administration stated that a competitor product, MorphaBond, “has marketing exclusivity for labeling describing the expected reduction of abuse of single-entity extended-release morphine by the intranasal route due to physicochemical properties.” Because of MorphaBond’s exclusivity within this market, “no other single-entity extended-release morphine product submitted in an abbreviated new drug application or 505(b)(2) application can be approved for that use at this time.” When this information was revealed to the investing public, the value of Egalet stock fell, causing investors serious harm.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456075

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Psychemedics Corporation (“Psychemedics” or the “Company”) (NASDAQ: PMD) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired shares between February 28, 2014 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On January 31, 2017, it was publicized that Psychemedics Brasil Exames Toxicologicos Ltda., Psychemedics’ Brazilian representative, will compensate Omega Laboratories, Inc. USA for losses from anticompetitive practices that are used for “preventing other companies from accessing [the] market.”

When this information was released to the investing public, shares of Psychemedics fell, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 456072

IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Global Eagle Entertainment Inc., and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Global Eagle Entertainment Inc. (“Global Eagle” or the “Company”) (NASDAQ: ENT). Investors, who purchased or otherwise acquired Global Eagle shares between November 9, 2016, and February 20, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 24, 2017 lead plaintiff deadline.

If you purchased shares of Global Eagle during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On February 21, 2017, Global Eagle revealed that its CEO, Dave Davis, and CFO, Tom Severson, had both left Global Eagle. The Company also noted that it cannot file its 2016 annual report on time, and will withdraw its guidance for its 2016 financial performance.

When this news was revealed to the investing public, the value of Global Eagle fell, causing investors serious harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456065

CopperBank Appoints Independent Director, Brigitte Dejou, and Technical Advisor, Colin Burge

VANCOUVER, BC / ACCESSWIRE / February 27, 2017 / CopperBank Resources Corp. (“CopperBank” or the “Company”) (CSE: CBK) (OTC PINK: CPPKF) announces that it has appointed Brigitte Dejou as an independent director and Colin Burge has joined the company’s technical advisory team.

Mr. Kovacevic comments, “I have known Brigitte and Colin for many years and have direct experience with both of them. CopperBank’s technical team now comprises of ten shareholder aligned members who have a combined two hundred and fifty years of industry experience. Colin was a vital element to the team at Cobre Panama, who delineated a tremendous amount of additional pounds of copper from the time I was an investor in the early development of that project. Brigitte has a deep knowledge base that rounds out our technical team, especially due to her direct experience in Alaska, where she participated with the geological interpretation that added many years of mine life to TECK’s Red Dog mine district. Both Brigitte and Colin will be great assets to CopperBank’s stakeholders as we continue our thorough data analysis and plan the important next steps for the Pyramid Copper porphyry deposit, The San Diego Bay prospect and our Contact Copper Oxide Project.”

Ms. Dejou holds both a Bachelor of Engineering degree and a Masters of Applied Science degree from Ecole Polytechnique de Montréal and is a member of the Ordre des Ingénieurs du Québec. Ms. Dejou has 25 years of experience in mineral exploration, including 18 years within Teck Cominco (now TECK) managing various exploration programs and two years with Osisko Mining Corporation working on the evaluation of new projects and QA/QC of existing drilling programs (Canadian Malartic, Duparquet, Hammond Reef). Ms. Dejou brings a wealth of experience in running a variety of exploration projects from grass-roots to pre-feasibility stage across North America (including Red Dog, El Limon-Morelos, Polaris, and Mesaba). She was also instrumental in the discovery of the Aktigiruk deposit. She has explored for a variety of commodities both for base metals (sedex and MVT Zn-Pb, porphyry Cu, magmatic Cu-Ni, VMS) and precious metals (Au, Ag, PGE). Since 2012, Ms. Dejou is Vice President Exploration for LaSalle Exploration.

Mr. Burge is a discovery oriented exploration geologist with 30 years’ experience in project development with First Quantum Minerals and predecessor companies. Mr. Burge was part of a corporate development team at Inmet Mining Corp. that discovered and delineated more than 30 billion pounds of copper at the Cobre Panama Project, leading to First Quantum Minerals $5 billion dollar acquisition of the company. He gained valuable experience working with First Quantum for 3 years as the project transitions to a mining operation and has excellent technical skills in exploration data management and the application of exploration tools, as well as a strong ability to think creatively. Mr. Burge graduated from the University of Waterloo with a Bachelor of Earth Science in 1981 and is a licensed professional geologist in British Columbia.

Shareholders are encouraged to visit the Company’s website for further details and biographies of each individual of CopperBank’s technical team:
www.copperbankcorp.com

The Company also announces that Robert McLeod will be stepping down from the Board of Directors and will remain as an important member of CopperBank’s technical team. Mr. McLeod will remain as a Qualified Person for the company.

On behalf of CopperBank Resources Corp.

“Gianni Kovacevic”
Executive Chairman

Address: Suite 1500, 409 Granville Street, Vancouver, BC V6C 1T2
Tel: 604-889-0852
E-mail: gk@copperbankcorp.com
Website: www.copperbankcorp.com

Certain information in this release may constitute “forward-looking information” under applicable securities laws and necessarily involve risks and uncertainties. Forward-looking information included herein is made as of the date of this news release and CopperBank does not intend, and does not assume any obligation, to update forward-looking information unless required by applicable securities laws. Forward-looking information relates to future events or future performance and reflects management of CopperBank’s expectations or beliefs regarding future events. In certain cases, forward-looking information can be identified by the use of words such as “plans,” or “believes,” or variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “would,” “might,” or “will be taken,” “occur,” or “be achieved,” or the negative of these terms or comparable terminology. Examples of forward-looking information in this news release include, but are not limited to, statements with respect to the Company’s ongoing review of its existing portfolio, the involvement of CopperBank in any potential divestiture, spin-out, partnership, or other transactions involving the Company’s portfolio assets, and the ability of the Company to complete any such transactions, the ability of CopperBank to enter into transactions that will ultimately enhance shareholder value, and the anticipated issuance of one million shares in connection with the satisfaction of certain loans between CopperBank and management. This forward-looking information is based, in part, on assumptions and factors that may change or prove to be incorrect, thus causing actual results, performance, or achievements to be materially different from those expressed or implied by forward-looking information. Such factors and assumptions include, but are not limited to the Company’s ability to identify and complete one or more transactions involving the Company’s
portfolio assets that enhance shareholder value as part of management’s ongoing review of strategic alternatives in the current market conditions. By its very nature, forward-looking
information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by forward-looking information. Such factors include, but are not limited to, the risk that the Company will not be able to identify and complete one or more transactions involving the Company’s portfolio assets that enhance shareholder value as part of management’s ongoing review of strategic
alternatives in the current market conditions. Although CopperBank has attempted to identify important factors that could cause actual actions, events, or results to differ materially from forward-looking information, there may be other factors that cause actions, events, or results not to be as anticipated, estimated, or intended. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated by such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. For more information on CopperBank and the risks and challenges of its businesses, investors should review the continuous disclosure filings that are available under CopperBank’s profile at www.sedar.com.

SOURCE: CopperBank Resources Corp.

ReleaseID: 456071

Removal Firm Faces Backlash Over Name – Isis Relocation

The name was chosen in honour of a protective and nurturing Egyptian goddess. However, the rise of the Islamic terrorist group means that an ancient deity is not the first association people make when they hear the word Isis.

Milton Keynes, Buckinghamshire, UK – February 27, 2017 /MarketersMedia/

A Well established Milton Keynes removals firm has been struggling to expand – because its name is Isis Relocation Ltd.

The name was chosen in honour of a protective and nurturing Egyptian goddess. However, the rise of the Islamic terrorist group means that an ancient deity is not the first association people make when they hear the word Isis.

The domestic and business removals company is a family business owned by Gabby Gomes, who has been in the industry for over 30 Years. Mr Gomes says he’s now experiencing a backlash because of the long-held name, and some potential clients have even refused to do business with him because of it.

He is having trouble convincing strangers that their negative reactions are unwarranted. Even though there are no rational grounds to suspect he has an association, or sympathises, with the Islamic extremists.

It means the plans to expand Isis Relocation Ltd have hit difficulties, and Mr Gomes is fighting to get them back on track. He said: Being Christian “We have no links whatsoever with the terrorist group, but the name alone seems to be putting people off. We even had to go as far as stating why we chose the name ISIS Relocation on our website home page.”

It has been suggested that Mr Gomes should change his company name, but this is not an option he wants to pursue. He has been building up a trusted reputation not just for removals in Milton Keynes, but for removals in Buckinghamshire,and surrounding areas. So, a new name would in many ways mean starting all over again.

Then there’s the matter of how much a new name would cost in rebranding expenses. The words Isis Relocation can be found on Mr Gomes’ warehouse, every one of his work vehicles and all of his packing materials. They also feature on promotional materials and online marketing.

The message that has been posted on the Isis Relocation website is aimed at reassuring potential customers, and the general public, of Mr Gomes’ good intent. It states: “The name Isis was chosen by one of our children whilst studying Egyptology many years ago. Isis is an Egyptian Goddess known for her caring and understanding nature and these are both attributes we like to incorporate ourselves when dealing with clients.”

Below the message, Mr Gomes has provided a link to an Encyclopedia Britannica webpage about the goddess Isis. It tells people she is of the most important ancient Egyptian deities and was revered for her role as a healer, principle mourner and mother. As her cult following grew, she was worshipped all across the Roman Empire – everywhere from Afghanistan to England.

As a proud member of the Alliance of Independent Movers, Mr Gomes hopes the more detailed explanation will help people understand there was an innocent reason why he named his firm Isis Relocation. He takes his reputation extremely seriously and would like anyone who has any doubts about his business to read the glowing reviews posted by satisfied customers.

Contact Info:
Name: Isis Relocation Ltd
Email: info@isis-relocation.co.uk
Organization: Isis Relocation Ltd
Address: Unit B 11 Bilton Road Bletchley
Phone: 01908 311001

Video URL: https://www.youtube.com/watch?v=NDJGR2S1quE

Source URL: http://marketersmedia.com/removal-firm-faces-backlash-over-name-isis-relocation/173507

For more information, please visit http://www.isis-relocation.co.uk/

Source: MarketersMedia

Release ID: 173507

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against ReWalk Robotics Ltd. and Encourages Investors with Losses to Contact the Firm

.LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against ReWalk Robotics Ltd (“Rewalk” or the “Company”) (NASDAQ: RWLK). Investors, who purchased or otherwise acquired Rewalk shares pursuant and/or traceable to the Company’s Stock Offering on or about September 12, 2014, are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The Complaint alleges that during the Class Period, the Registration Statement and Prospectus issued regarding the Initial Public Offering did not disclose material information, including that ReWalk did not comply with “special controls” requirements.

When this information was revealed to the investing public, the value of Rewalk fell, causing investors serious harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 456056

CEO Evaluation and Board Evaluation Platform Streamlines Corporate Governance

The Center for Board Excellence provides innovative, director-centric governance tools for board evaluations, CEO evaluations and other regulatory compliance exercises. We streamline inefficient document-based processes so that directors and governance professionals can focus on what they do best: provide strategic advisement impacting a company’s performance.

CEO Evaluation and Board Evaluation Platform Streamlines Corporate Governance

Greensboro, United States – February 27, 2017 /PressCable/

The Center for Board Excellence (CBE) announces the release of EnGaugeTM, the next-generation board and CEO evaluation platform designed to promote deeper board and management engagement. “EnGauge is designed and built to serve and adapt to the evolving needs of boards, CEOs and the professionals who support governance within an organization,” said Byron Loflin, CBE’s founder and CEO.

While EnGauge has emerged as the leading board and CEO board evaluation platform, it is also priced in line with the cost consciousness of most enterprises today. The EnGauge process includes both online and telephonic interview questionnaire libraries as well as unique reporting capabilities.

EnGauge is a user friendly, non-invasive evaluation methodology that is both customizable and flexible to the user’s needs. The vision of CBE and the EnGauge platform aims to be a catalyst for promoting and executing their clients’ corporate strategy. Utilizing EnGauge fosters open, constructive, collegial interaction among an organization’s leadership, promoting credible challenge and constructive dissent, two key elements that lead to corporate governance excellence.

“Your online questionnaire and interview process produced the best board evaluation report that I have seen in my over 20 years as a public company director.” — Fortune 500 company director

“I have just gone through a board evaluation process with The Center for Board Excellence… I would strongly recommend their organization.” — CEO of leading private company

About the Center for Board Excellence

Founded in 2010, The Center for Board Excellence provides innovative, governance tools for board evaluations, CEO evaluations and other regulatory compliance exercises. CBE streamlines laborious, inefficient, costly, document-based processes so that directors and governance professionals can focus on what they do best: provide strategic advisement and guidance on matters that critically impact a company’s performance.

As a trusted, third-party professional services provider, CBE works closely with public company boards, private company boards, CEOs and not for profits. Clients include many members of the Fortune 500 and Forbes’ 100 Most Trustworthy Companies, who know the value of CBE’s unique performance assessment reporting.

# # #

For more information, visit www.boardevaluations.com/ceo-evaluations. Or to schedule an EnGauge demo, contact Anne Kelso at 800.645.1976 or anne@boardevaluations.com.

Contact Info:
Name: Anne Kelso
Organization: The Center for Board Excellence
Address: 245 East Friendly Avenue Suite 240, Greensboro, NC 27401, United States
Phone: +1-800-645-1976

For more information, please visit http://www.boardevaluations.com/ceo-evaluations

Source: PressCable

Release ID: 173516

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Roadrunner Transportation Systems Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Roadrunner Transportation Systems Inc. (“Roadrunner” or the “Company”) (NYSE: RRTS). Investors, who purchased or otherwise acquired Roadrunner shares between May 8, 2014 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 03, 2017 lead plaintiff deadline.

If you purchased shares of Roadrunner during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Roadrunner revealed on January 30, 2017 that its financial statements would need to be reissued. The Company revealed a few accounting mistakes that it anticipates will necessitate changes of $20 million to $25 million. The Company mentioned that it is currently being investigated.

When this information was released to the public, the value of Roadrunner fell, causing investors harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456054

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors it Has Filed a Complaint to Recover Losses Suffered by Investors in Anthera Pharmaceuticals, Inc.

NEW YORK, NY / ACCESSWIRE / February 27, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Anthera Pharmaceuticals, Inc. (“Anthera”) (NASDAQ: ANTH) between February 10, 2015 and December 27, 2016. You are hereby notified that Levi & Korsinsky has commenced the class action, Clevlen v.
Anthera Pharmaceuticals, Inc., et al. (Case No. 3:17-cv-715), in the USDC for the Northern District of California. Click here to view the complaint. To get more information, go to: http://www.zlk.com/pslra/anthera-pharmaceuticals-inc, or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, among other allegations, throughout the Class Period, Anthera made materially false and/or misleading statements concerning the potential efficacy and success of its Solution Study and CHABLIS-SC1 clinical trials, as the Company failed to disclose that: (i) patients were not improving in the CHABLIS-SC1 clinical trial; and (ii) there were dosing problems inherent in the Solution Study design that created challenges to obtaining responses.

On November 10, 2016, the Company issued a press release announcing that the CHABLIS-SC1 clinical trial with blisibimod for the treatment of SLE failed to meet its primary endpoint. Following this news, shares of Anthera fell approximately 32% to close at $1.90 on November 10, 2016. Then, on December 27, 2016, the Company issued another press release announcing that the Solution clinical study in cystic fibrosis patients with EPI missed the CFA non-inferiority margin of the primary modified Intent to Treat. Following this news, shares of Anthera fell approximately 63% to close at $0.74 on December 28, 2016.

Take Action: if you suffered a loss in Anthera, you have until April 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York,
NY10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 456070